Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.

• Tác giả: Michael Bukhalo, Antonio Costanzo, Leonidas Drogaris, Yu-Huei Huang, Nadia Ibrahim, Georgios Kokolakis, Neil J Korman, Lev Pavlovsky, Andreas Pinter, Simone Rubant, Ahmed M Soliman, Vassilis Stakias, Diamant Thaçi, Richard B Warren, Yanbing Zheng
• Ngôn ngữ: eng
• Ký hiệu phân loại: 025.27 Acquisition of and collection development for materials on specific disciplines and subjects
• Thông tin xuất bản: Switzerland : Dermatology and therapy , 2025
• Bộ sưu tập: NCBI
• ID: 176977